SPYRE THERAPEUTICS, INC. Debt Securities, Available-for-sale
SPYRE THERAPEUTICS, INC. (SYRE) had Debt Securities, Available-for-sale of $52.70 million as of 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2020-02-24
- 2019-12-31: Debt Securities, Available-for-sale $52.70M.
- 2019-03-31: Debt Securities, Available-for-sale $38.07M.
- 2018-12-31: Debt Securities, Available-for-sale $52.05M.
- 2018-09-30: Debt Securities, Available-for-sale $50.20M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2019-12-31 | $52.70M 10-K · filed 2020-02-24 |
| 2019-03-31 | $38.07M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $52.05M 10-K · filed 2020-02-24 |
| 2018-09-30 | $50.20M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $51.61M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $37.48M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |